Literature DB >> 10999828

Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations.

A L Schneyer1, T Fujiwara, J Fox, C K Welt, J Adams, G M Messerlian, A E Taylor.   

Abstract

Previous studies of normal human ovaries suggest that inhibins, activins, and follistatin (FS) are produced in a stage-specific pattern indicative of intraovarian, autocrine/paracrine roles in regulating follicle development. However, these studies relied largely on surgical specimens and thus include little information about the menstrual cycle stage or dominant follicle status at the time follicles or ovaries were obtained. The purpose of this study was to 1) determine the pattern of intrafollicular hormone biosynthesis across antral follicle development in normal women, 2) compare hormone concentrations in dominant and nondominant follicles from the same ovary, and 3) examine the relationship between dominant follicle hormone content and circulating hormone levels. Intrafollicular estradiol, progesterone, and inhibin A concentrations increased significantly with follicle size or maturity, whereas significant inverse relationships were observed for androstenedione and the androstenedione/estradiol (A:E) ratio. In contrast, neither inhibin B, activin A, nor free FS varied consistently with size or maturity. Estradiol, progesterone, and inhibin A levels and A:E ratio were significantly lower in nondominant follicles compared to the dominant follicle aspirated from the same ovary. Although intrafollicular and serum concentrations of each hormone followed the same general pattern as follicles develop, the human follicular fluid/serum gradients changed during the follicular phase and were different for estradiol and inhibin A, suggesting the presence of stage-specific differences in pharmacodynamics. These results are consistent with the hypothesis that the orderly transition from an activin-dominant to an inhibin A/FS-dominant microenvironment is critical for dominant follicle development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999828     DOI: 10.1210/jcem.85.9.6767

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  21 in total

1.  Modeling and simulation of pathways in menopause.

Authors:  Dimitra Tsavachidou; Michael N Liebman
Journal:  J Am Med Inform Assoc       Date:  2002 Sep-Oct       Impact factor: 4.497

2.  Plasma concentrations of ir-inhibin, inhibin A, inhibin pro-alphaC, FSH, and estradiol-17beta during estrous cycle in mares and their relationship with follicular growth.

Authors:  Mohamed S Medan; Yasuo Nambo; Natsuko Nagamine; Hiromi Shinbo; Gen Watanabe; Nigel Groome; Kazuyoshi Taya
Journal:  Endocrine       Date:  2004-10       Impact factor: 3.633

3.  Luteal-phase inhibin A and follicular-phase inhibin B levels are not characteristic of patients with an elevated LH-to-FSH ratio.

Authors:  Erik E Hauzman; Péter Fancsovits; Akos Murber; Thomas Rabe; Thomas Strowitzki; Zoltán Papp; János Urbancsek
Journal:  J Assist Reprod Genet       Date:  2006-03       Impact factor: 3.412

4.  Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women.

Authors:  N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J M Adams; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

5.  Inhibin α-subunit N terminus interacts with activin type IB receptor to disrupt activin signaling.

Authors:  Jie Zhu; S Jack Lin; Chao Zou; Yogeshwar Makanji; Theodore S Jardetzky; Teresa K Woodruff
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

6.  Expression of inhibin-activin subunits, follistatin and smads in granulosa-luteal cells collected at oocyte retrieval.

Authors:  Shiuh Young Chang; Hong-Yo Kang; Kuo-Chung Lan; Chang-Yi Hseh; Fu-Jen Huang; Ko-En Huang
Journal:  J Assist Reprod Genet       Date:  2006-10-12       Impact factor: 3.412

7.  Compensatory Increase in Ovarian Aromatase in Older Regularly Cycling Women.

Authors:  N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J A Adams; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2015-06-30       Impact factor: 5.958

Review 8.  Neuroendocrine, autocrine, and paracrine control of follicle-stimulating hormone secretion.

Authors:  Vasantha Padmanabhan; Rodolfo C Cardoso
Journal:  Mol Cell Endocrinol       Date:  2019-11-02       Impact factor: 4.102

Review 9.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

Review 10.  Polycystic ovary syndrome and its developmental origins.

Authors:  Daniel A Dumesic; David H Abbott; Vasantha Padmanabhan
Journal:  Rev Endocr Metab Disord       Date:  2007-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.